Landscape Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Other funds holding IOVA
MFM
PA
LFCM
HRCM
SCM
Landscape Capital Management's IOVA Position: Q1 2025 in Review
Landscape Capital Management sold out of Iovance Biotherapeutics (IOVA) in Q1 2025, closing a stake of 106,884 shares — an estimated $791K sold.
Landscape Capital Management first reported a position in IOVA in Q1 2015 and held it in 19 quarters. The position peaked at $1.05M in Q2 2016. 302 funds tracked by Wall St. Rank hold IOVA as of Q1 2025.
- Landscape Capital Management reported no remaining Iovance Biotherapeutics position as of Q1 2025 after selling out during the quarter.
- Landscape Capital Management sold 106,884 Iovance Biotherapeutics shares in Q1 2025, an estimated $791K.
- Landscape Capital Management first reported a position in Iovance Biotherapeutics in Q1 2015 and held it in 19 quarters.
- Landscape Capital Management's Iovance Biotherapeutics position peaked at $1.05M in Q2 2016.
- 302 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2025.
Based on Landscape Capital Management's 13F filing for Q1 2025, filed 14 May 2025.